Back to companies
Regencell Bioscience Holdings Ltd
RGCCNNASDAQPharmaceuticals & HealthcareRegencell Bioscience Holdings Ltd
Revenue
—
FY2026
Operating income
-$11.7mn
FY2026
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API